Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2013
06/27/2013WO2013096051A1 Compounds for inhibiting the interaction of bcl2 with binding partners
06/27/2013WO2013096049A1 Compounds for inhibiting the interaction of bcl2 with binding partners
06/27/2013WO2013095743A1 High quality antimicrobial paint composition
06/27/2013WO2013095708A1 Novel neuromodulatory compounds
06/27/2013WO2013095707A1 Novel iso-ergoline derivatives
06/27/2013WO2013095684A1 Guanine analogs as telomerase substrates and telomere length affectors
06/27/2013WO2013095681A1 Methods and compositions for the treatment of diverticulosis
06/27/2013WO2013095321A1 Heroin haptens, immunoconjugates and related uses
06/27/2013WO2013095320A1 Flurbiprofen formulations
06/27/2013WO2013095319A2 Formulations of flurbiprofen and diacerein
06/27/2013WO2013095318A2 Orally-disintegrating formulations of flurbiprofen
06/27/2013WO2013095317A2 Pharmaceutical formulations of flurbiprofen and glucosamin
06/27/2013WO2013095316A1 Synergic combination comprising anti-diabetic agent
06/27/2013WO2013095315A1 Formulations comprising dexketoprofen (particle size 300-2500 micrometer)
06/27/2013WO2013095314A1 Pharmaceutical formulations comprising risperidone
06/27/2013WO2013095313A1 Pharmaceutical formulations comprising cefdinir
06/27/2013WO2013095312A1 Formulations comprising quetiapine fumarate
06/27/2013WO2013095307A1 New crystal salts of zofenopril, process for obtaining them and their use in therapy
06/27/2013WO2013095286A2 Synergistic combination for tumor inhibition
06/27/2013WO2013095279A1 Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
06/27/2013WO2013095277A1 Use of chemically modified heparin derivates in sickle cell disease
06/27/2013WO2013095276A1 Low anticoagulant heparins
06/27/2013WO2013095275A1 Novel hepatitis c virus inhibitors
06/27/2013WO2013095270A1 An aqueous solution comprising a macromolecular conjugate of heparin for the treatment of blood vessels
06/27/2013WO2013095215A1 Low anticoagulant heparins
06/27/2013WO2013095169A1 Crystalline minocycline thermo-resistant obtained by recrystallization with carbon dioxide
06/27/2013WO2013095166A1 Antibiotic formulations
06/27/2013WO2013095132A1 Mirna for treating head and neck cancer
06/27/2013WO2013095111A1 Simethicone formulation
06/27/2013WO2013095060A1 6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis
06/27/2013WO2013095042A2 Granule containing imatinib mesylate, immediate release oral tablet composition containing same, and preparation method thereof
06/27/2013WO2013095027A1 Anti-inflammation composition using vladinol f
06/27/2013WO2013094903A1 Persimmon leaf-derived sugar fraction having immune function boosting activity and method for producing same
06/27/2013WO2013094761A1 Novel s1p receptor modulator
06/27/2013WO2013094676A1 Hydroxymethylfurfural derivative
06/27/2013WO2013094581A1 Novel camptothecin derivative
06/27/2013WO2013094489A1 Method for preparing hair growth agent, and composition prepared by said method
06/27/2013WO2013093940A1 Nitrofurfuryl substituted phenyl linked piperidino-oxadiazoline conjugates as anti-tubercular agents and process for the preparation thereof
06/27/2013WO2013093934A1 Process for preparation of decitabine injection
06/27/2013WO2013093885A1 Inhibitors of notch signalling pathway and use thereof in treatment of cancers
06/27/2013WO2013093880A1 Use of steviol, of a steviol glycoside derivative or of one of their isomers to prevent, reduce and/or treat a detrimental change in the complexion of the skin
06/27/2013WO2013093870A1 microRNAs FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION
06/27/2013WO2013093850A1 Quinoline derivatives
06/27/2013WO2013093849A1 Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
06/27/2013WO2013093842A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
06/27/2013WO2013093790A1 A composition for reducing an hiv viral load comprising praziquantel, niclosamide and albendazole
06/27/2013WO2013093753A1 Ivabradine hydrochloride premix
06/27/2013WO2013093688A1 Sulfonamide derivatives and use thereof as vgsc inhibitors
06/27/2013WO2013093659A1 Natural, multiple release and re-use compositions
06/27/2013WO2013093655A1 Non-enteric pharmaceutical composition comprising crofelemer
06/27/2013WO2013093615A1 Tricyclic boron compounds for antimicrobial therapy
06/27/2013WO2013093508A2 Wnt pathway inhibitors
06/27/2013WO2013093497A1 2 - (pyridin- 2yl) - 1, 7 -diaza- spiro [4.4] nonane- 6 -one compounds as voltage - gated sodium channels modulators
06/27/2013WO2013093496A1 2 - (pyridin- 2yl) - 1, 7 -diaza-spiro [4.4] nonane- 6 -one compound as voltage-gated sodium channels modulator
06/27/2013WO2013093493A1 Novel rapamycin analogue
06/27/2013WO2013093484A1 Pyridinone and pyrimidinone derivatives as factor xia inhibitors
06/27/2013WO2013093481A1 Fluorescent dyes based on acridine and acridinium derivatives
06/27/2013WO2013093379A1 Novel pharmaceutical compositions comprising an antibody which binds the human anti-mullerian hormone receptor type ii
06/27/2013WO2013093248A1 Novel combinations containing n-hydroxy-4-(2-[3-(n, n-dimethylaminomethyl) benzofuran-2-ylcarbonylamino]ethoxy)benzamide in nasopharyngeal carcinoma
06/27/2013WO2013093164A1 Tranexamic acid gel
06/27/2013WO2013093137A1 Learning enhancing compounds
06/27/2013WO2013093102A1 Ellagitannins rich extracts composition
06/27/2013WO2013093096A1 Ellagitannins rich extracts composition in sexual wellness
06/27/2013WO2013093095A1 Bisarylsulfonamides useful in the treatment of inflammation and cancer
06/27/2013WO2013093019A1 Acridinedione derivatives for treating pigmentation disorders and ageing of the skin
06/27/2013WO2013092984A1 Combination of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent
06/27/2013WO2013092979A1 Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
06/27/2013WO2013092976A1 New piperidine derivatives, pharmaceutical compositions and uses thereof
06/27/2013WO2013092942A1 Use of aminobenzamide derivatives for controlling animal parasites
06/27/2013WO2013092941A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS
06/27/2013WO2013092940A1 2, 4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors
06/27/2013WO2013092939A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS
06/27/2013WO2013092936A2 Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
06/27/2013WO2013092918A1 Novel therapeutic use of p75 receptor antagonists
06/27/2013WO2013092900A1 Synthesis of triazolopyrimidine compounds
06/27/2013WO2013092893A1 Chemical compounds
06/27/2013WO2013092868A1 N-thio-anthranilamide compounds and their use as pesticides
06/27/2013WO2013092860A2 Hyaluronic acid and its use for treating venous insufficiency and varicose veins
06/27/2013WO2013092854A1 Pyrimidine-2,4-diamine derivatives as kinase inhibitors
06/27/2013WO2013092791A1 Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
06/27/2013WO2013092786A1 Compositions comprising cetilistat
06/27/2013WO2013092756A1 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
06/27/2013WO2013092753A1 Indole derivatives inhibitors of enzyme lactate dehydrogenase (ldh)
06/27/2013WO2013092739A1 [1,2,4]triazolopyridines and their use as phospodiesterase inhibitors
06/27/2013WO2013092711A1 Trpm8 antagonists
06/27/2013WO2013092674A1 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
06/27/2013WO2013092673A2 New combination
06/27/2013WO2013092616A1 New aziridine compounds, pharmaceutical compositions and their use as acetyl-coa carboxylase inhibitors
06/27/2013WO2013092589A1 Multiple unit pellet tablet formulation comprising an opioid
06/27/2013WO2013092574A1 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals
06/27/2013WO2013092558A1 Preparations containing amorphous emodepside
06/27/2013WO2013092556A1 Metal-chelating compounds having at least one polyamino chain
06/27/2013WO2013092512A1 Substituted benzylpyrazoles
06/27/2013WO2013092509A1 Inhibitors of sialoadhesin for the treatment of diseases caused by enveloped viruses
06/27/2013WO2013092497A1 Immediate release multi unit pellet system
06/27/2013WO2013092481A1 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
06/27/2013WO2013092467A1 7-azaindole inhibitors of crac
06/27/2013WO2013092463A1 4-azaindole inhibitors of crac
06/27/2013WO2013092447A1 4'-azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
06/27/2013WO2013092444A1 Diazaindole inhibitors of crac
1 ... 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 ... 7860